Technology solutions such as AR/VR and conferencing that seek to overcome the social distancing barriers to collaboration, productivity, and information dissemination have become ever so important.
In this week’s featured patents, we cover the latest patent applications from Intel, IBM, Apple, Microsoft, Novartis, Roche, Medtronic, and Boston Scientific.
Intel Files a Patent for Optimizing Head-Mounted Displays for Augmented Reality
U.S. patent application, 20200184728, discloses a virtual reality system having an opaque and enclosed screen repurposed for augmented reality use. The system may use procedural mapping methods to generate a virtual model of the environment to supplement an anticipatory rendering. The illustration depicts an overview of environment data capture, model creation, and model application.
IBM Seeks a Patent for a Method for Suggesting Behavioral Adjustments During Video Conferences
U.S. patent application, 20200184203, discloses a method for suggesting behavioral adjustments for participants in a video conference based on comparing the baseline emotive states and the current emotive states of the participants. The figure below illustrates an example user interface that displays suggested behavioral adjustments to the participants during video conferencing.
Apple Wants a Patent for a User Interface for Always-On Audio Control for a Mobile Device
US patent application 20200184976 discloses a circuit for capturing a user’s audio samples to detect a possible command from the user even when the CPU is initializing and the operating system is booting. A timing diagram illustrating the concept is shown below.
Microsoft Aims to Patent a System for Matching the Urgency and Emotion State of the User to the Urgency for Scheduling a Meeting Automatically via Artificial Intelligence
U.S. patent application, 20200186482, discloses a digital assistant that receives a message from a user, detects the user’s intent to schedule a meeting and identifies an urgency level associated with the message. Based on the urgency level, the digital assistant responds and performs a follow-up action, if required. A block diagram illustrating the concept is shown below.
Medtronic Seeks Patents for Systems for Peritoneal Dialysis and for Rejection of Ventricular Tachyarrhythmia Detection
U.S. patent application, 20200179583, describes a system for personalized peritoneal dialysis therapy which calculates the desired dialysis adequacy for a specific patient based on the measured peritoneal dialysate concentration and the volume obtained from flow sensors and uremic solute sensors. The figure below shows the peritoneal dialysis cycler.
Another application, 20200178830, discloses an implantable cardioverter-defibrillator (ICD) that detects noise-contaminated cardiac signal segments and rejects a ventricular tachyarrhythmia detection in response to detecting noisy signal segments using a threshold. The figure below shows the ICD system implanted in a patient.
Novartis Wants to Patent an Ocular Implant
U.S. patent application, 20200179170, describes an ocular implant with an elongate member having an internal lumen forming a flow pathway, an inflow port communicating with the flow pathway, and an outflow port communicating with the flow pathway. The illustration below shows the implant positioned in the eye.
Roche Aims to Patent an Inspection Device
US patent application 20200182836 presents an inspection device having a particle detector adapted to detect particles in a liquid, a seat adapted to position a container housing the liquid in an area for the operation of the particle detector, and a vibration arrangement for vibrating the container. The image below shows the inspection device.
Boston Scientific Seeks to Patent a Multi-Lumen-Catheter Retractor System
US patent application 20200178948 presents devices for performing endoscopic surgery comprising a surgical suite that provides a reversibly-expandable retractor that expands to provide a stable, operative environment within a subject. The figure below shows a system for operatively treating gastrointestinal disorders using the described devices.